The presence of a JAK2 V617F mutation failed to reach statistical significance as a risk factor for arterial or venous events (HR, 1.38; 95% CI, 0.92-2.07; P = .12).
← all excerpts
Thrombosis in primary myelofibrosis: the influence of cohort composition and disease biology.
1
0.1200
0.1200